Population Pharmacokinetic Model of Adalimumab Based on Prior Information Using Real World Data.

Marquez-Megias S, Nalda-Molina R, Más-Serrano P, Ramon-Lopez A

DOI: 10.3390/biomedicines11102822
Published: 2023 Oct 18
Container: Biomedicines
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3390/biomedicines11102822,
  title = {Population Pharmacokinetic Model of Adalimumab Based on Prior Information Using Real World Data.},
  author = {Marquez-Megias S and Nalda-Molina R and Más-Serrano P and Ramon-Lopez A},
  year = {2023},
  journal = {Biomedicines},
  doi = {10.3390/biomedicines11102822},
  url = {https://doi.org/10.3390/biomedicines11102822}
}

RIS

TY  - JOUR
TI  - Population Pharmacokinetic Model of Adalimumab Based on Prior Information Using Real World Data.
AU  - Marquez-Megias S
AU  - Nalda-Molina R
AU  - Más-Serrano P
AU  - Ramon-Lopez A
PY  - 2023
JO  - Biomedicines
DO  - 10.3390/biomedicines11102822
UR  - https://doi.org/10.3390/biomedicines11102822
ER  -

APA

S, M., R, N., P, M., & A, R. (2023). Population Pharmacokinetic Model of Adalimumab Based on Prior Information Using Real World Data.. Biomedicines. https://doi.org/10.3390/biomedicines11102822

Source records

pubmed · retrieved 2026-09-26T19:20:25.879Z